head and neck squamous cell carcinoma

Showing 1 - 25 of 239

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head and Neck Squamous Cell Carcinoma, Melanoma Excluding Uveal Melanoma, NSCLC, Squamous or Non-squamous Trial in Denver,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +8 more
  • XmAb®808
  • Keytruda® (pembrolizumab)
  • Denver, Colorado
  • +1 more
Oct 21, 2022

Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

Not yet recruiting
  • Oropharyngeal Cancer
  • +10 more
  • (no location specified)
Oct 13, 2022

Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)

Not yet recruiting
  • Head and Neck Cancer
  • +2 more
  • Pegsitacianine
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Oct 8, 2022

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial (IMT-009)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • (no location specified)
Sep 29, 2022

Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

Not yet recruiting
  • Cervical Cancer
  • +13 more
  • (no location specified)
Sep 28, 2022

Head Neck Cancer, Head and Neck Carcinoma, Head and Neck Tumors Trial in United States (diagnostic test, radiation, drug)

Recruiting
  • Head and Neck Cancer
  • +3 more
  • 18F-FMISO PET/CT scan
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Sep 15, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Larynx Trial (Hypofractionated

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Hypofractionated Postoperative Radiotherapy
  • (no location specified)
Sep 12, 2022

Breast Cancer, Glioblastoma, Head and Neck Squamous Cell Carcinoma Trial (PRT3645)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Sep 9, 2022

Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

Active, not recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +19 more
  • Duarte, California
  • +18 more
Aug 24, 2022

Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Aug 23, 2022

Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Stage I Cutaneous Squamous Cell Carcinoma of the Head and

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Best Practice
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 19, 2022

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Squamous Cell Carcinoma,

Suspended
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +19 more
  • Cetuximab
  • +5 more
  • Birmingham, Alabama
  • +255 more
Aug 20, 2022

Head and Neck Squamous Cell Carcinoma Trial in France, Germany, Spain (Cisplatin, 5-Fluorouracile, Docetaxel)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Avignon, France
  • +16 more
Aug 22, 2022

Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

Terminated
  • Pancreatic Adenocarcinoma
  • +13 more
  • San Francisco, California
  • +7 more
Aug 17, 2022

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, NSCLC Trial in Boston, Saint Louis (ITIL-168)

Recruiting
  • Cervical Cancer
  • +2 more
  • ITIL-168
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 15, 2022

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York

Recruiting
  • Advanced Solid Tumor
  • +13 more
  • Duarte, California
  • +2 more
Aug 16, 2022

Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Magrolimab, Pembrolizumab, Docetaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Chandler, Arizona
  • +31 more
Aug 16, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Groningen (Fluorescence guided detection of tumor positive

Not yet recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Groningen, Netherlands
    University Medical Center Groningen
Aug 10, 2022

Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder Trial in Spain, United Kingdom,

Recruiting
  • Lung Cancer Non Small Cell
  • +2 more
  • IO102-IO103 in combination with pembrolizumab
  • Duarte, California
  • +11 more
Aug 11, 2022

Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)

Withdrawn
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • (no location specified)
Aug 1, 2022

Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

Recruiting
  • Gastric Cancer
  • +8 more
  • Scottsdale, Arizona
  • +4 more
Aug 2, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial in Houston (18F-FSPG, 11C-Glutamine)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Head and Neck Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jul 28, 2022

Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Nivolumab, HuMax-IL8, Cabiralizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins University
Jul 28, 2022

Head Neck Cancer, Head Cancer, Head Cancer Neck Trial in United States (drug, procedure, radiation)

Recruiting
  • Head and Neck Cancer
  • +5 more
  • Basking Ridge, New Jersey
  • +5 more
Jul 27, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +5 more
  • IK-175 + nivolumab
  • Chicago, Illinois
  • +3 more
Jul 26, 2022